Biotech research

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Biotech Stocks

Branded Products, Acquisitions To Be Allergan (NYSE:AGN) Focus

Results Of Agios Pharmaceuticals Inc (NASDAQ:AGIO) Midstage Trial Released

Here’s Why These Two Biotechnology Companies Took A Hit On Monday: Neothetics, Inc. (NASDAQ:NEOT) and Matinas BioPharma Holdings, Inc. (NYSEMKT:MTNB)

Novartis AG (ADR) (NYSE:NVS) Closing In On Kisqali Approval In Europe

BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Inks CVS Health Corp (NYSE:CVS) Deal

Here’s What Just Happened With Portola Pharmaceuticals Inc (NASDAQ:PTLA) and bluebird...

TESARO Inc (NASDAQ:TSRO) Might Outperform Rivals with Zejula

GlaxoSmithKline plc (ADR) (NYSE:GSK) Presents Positive Data From Phase III Shingles...

Here’s What’s Moving Novartis AG (ADR) (NYSE:NVS) and Kamada Ltd (NASDAQ:KMDA)

GlaxoSmithKline plc (ADR) (NYSE:GSK) To Receive $235M From Teva Pharmaceutical Industries...

UnitedHealth Group Inc (NYSE:UNH) Ranked In Top 50 Community-Minded Firms By...

Here’s What Just Happened With Cara Therapeutics, Inc. (NASDAQ:CARA) and ImmunoCellular...

Medtronic plc. (NYSE:MDT) CRT Devices Touted For Cost Saving Credentials

Biotech Movers: Egalet Corporation (NASDAQ:EGLT) and Neos Therapeutics, Inc. (NASDAQ:NEOS)

European Commission Clears Novartis AG (ADR) (NYSE:NVS) Blood Cancer Drug

EDITOR PICKS

Here’s Why These Two Biotechnology Companies Took A Hit On Monday:...

Here’s What Just Happened With Portola Pharmaceuticals Inc (NASDAQ:PTLA) and bluebird...

Here’s What’s Moving Novartis AG (ADR) (NYSE:NVS) and Kamada Ltd (NASDAQ:KMDA)

POPULAR POSTS

Vistagen Therapeutics Is A $17M Company With a Potentially $2.8B Drug

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

POPULAR CATEGORY